Catch up on the latest trends in health news in this roundup of long-reads compiled by Live Science's health channel editor.

Science has named the development of glucagon like peptide-1 (GLP-1) agonists and this year’s discovery that these drugs can blunt obesity-associated health problems as its 2023 Breakthrough of The ...

Forbes contributors publish independent expert analyses and insights. Scott Hutcheson teaches leadership at Purdue University. As the new year approaches, many of us begin to set resolutions—hopes and ...